Russian Federation (RU)

A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk (2018) Lu Y, Beeghly-Fadiel A, Wu L, Guo X, Li B, Schildkraut JM, Im HK, et al. Journal article The e-ASTROGAM gamma-ray space observatory for the multimessenger astronomy of the 2030s (2018) Tatischeff V, De Angelis A, Tavani M, Grenier I, Oberlack U, Hanlon L, Walter R, et al. Conference contribution Coding and Non-coding: Molecular Portrait of GIST and its Clinical Implication (2018) Bure I, Haller F, Zaletaev DV Journal article Projections for the changes in growing season length of tree-ring formation on the Tibetan Plateau based on CMIP5 model simulations (2018) He M, Yang B, Shishov V, Rossi S, Bräuning A, Ljungqvist FC, Grießinger J Journal article, Original article Tree rings reveal globally coherent signature of cosmogenic radiocarbon events in 774 and 993 CE (2018) Buntgen U, Wacker L, Galvan JD, Arnold S, Arseneault D, Baillie M, Beer J, et al. Journal article, Original article Projections for the changes in growing season length of tree-ring formation on the Tibetan Plateau based on CMIP5 model simulations (2018) He M, Yang B, Shishov V, Rossi S, Bräuning A, Ljungqvist FC, Grießinger J Journal article, Original article Erratum to: Tree rings reveal globally coherent signature of cosmogenic radiocarbon events in 774 and 993 CE (Nature Communications, (2018), 9, 1, (3605), 10.1038/s41467-018-06036-0) (2018) Buntgen U, Wacker L, Galvan JD, Arnold S, Arseneault D, Baillie M, Beer J, et al. Journal article, Erratum DNA methylation-based classification of central nervous system tumours (2018) Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, et al. Journal article Toward large scale modeling of carbon nanotube systems with the mesoscopic distinct element method (2018) Ostanin IA, Zhilyaev P, Petrov , Dumitrica T, Eibl S, Rüde U, Kuzkin VA Journal article, Original article Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial (2018) Hurvitz SA, Martin M, Symmans WF, Jung KH, Huang CS, Thompson AM, Harbeck N, et al. Journal article